NCT05853562

Brief Summary

Background: The vestibular rehabilitation is an exercise-based method, aiming to maximize central nervous system(CNS) compensation at vestibular nuclear and other CNS levels for vestibular pathology. A minimal number of studies have documented the impact of Vestibular rehabilitation on the recovery rate of patients with Bilateral Vestibular Hypofunction(BVH). Objective: The purpose of this study was to investigate the effectiveness of structured vestibular rehabilitation (VR) programs on severity of dizziness, kinesiophobia, balance, fatigue, quality of sleep, activities of daily living( ADL) and quality of life(QoL) in subjects with chronic BVH. Method: Twenty-five participants diagnosed with BVH were included in the study. A structured VR program was applied in 50-minute sessions once a week and as a home exercise program 3 days a week over 8 weeks. Participants were evaluated for severity of dizziness with the Visual Analog Scale (VAS), for kinesiophobia with the Tampa Scale of Kinesiophobia (TSK), for balance with the Semitandem, tandem, and standing tests, for quality of sleep with the Pittsburgh Sleep Quality Index (PSQI), for ADL with the Vestibular Disorders Activities of Daily Life (VADL), for QoL with Dizziness Handicap Inventory (DHI) and for fatigue with the Fatigue Severity Scale (FSS) at the baseline (T0), at 4th week (T1), 8th week (T2), and 20th week (T3) after study started.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

9 months

First QC Date

April 21, 2023

Last Update Submit

May 2, 2023

Conditions

Keywords

Bilateral Vestibular HypofunctionDizzinessKinesiophobiaBalanceQuality of SleepQuality of LifeStructured Exercise

Outcome Measures

Primary Outcomes (7)

  • Visual Analog Scale

    It is a validated, subjective scale used to measure the intensity or frequency of various symptoms. Scores are based on self-reported measures of symptoms that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale-"no symptom" on the left end (0 cm) of the scale and the "worst symptom" on the right end of the scale (10 cm). We used this scale to measure the severity of dizziness

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Tampa Scale of Kinesiophobia

    It is a 17 items self-reporting questionnaire based on evaluation of fear of movement, fear of physical activity, and fear avoidance. The total score of the scale ranges from 17- 68, where 17 means no kinesiophobia, 68 means severe kinesiophobia, and score ± 37 indicates there is kinesiophobia

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Semitandem, Tandem, and Standing tests

    Semitandem, Tandem, and Standing tests were used to evaluate balance. Semitandem test 30 , Tandem test 30 , Standing tests 30 Equilibrium times (sec) with eyes open-closed were recorded on hard and soft surfaces

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Pittsburgh Sleep Quality Index

    It is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. The seven component scores consist of subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Dizziness Handicap Inventory

    It is used to assess the impact of dizziness on quality of life. It consists of 25 clauses which determine the aggravating factors associated with dizziness and shakiness and also the emotional and functional results of vestibular system diseases. The inventory consists of 3 sub-dimensions, intended to determine physical, emotional and functional effects of the vestibular system diseases

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Fatigue Severity Scale

    It was used to assess fatigue. There are 9 questions in the scale and each question consists of 7 points. An increase in the scale score indicates an increase in the level of fatigue. It detects the state of fatigue in the last month

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

  • Vestibular Disorders Activities of Daily Life

    This scale is used to determine the degree of independence of patients with vestibular disorders, perceived inadequacies and vestibular complaints in daily activities. The scale consists of 28 items. The subscales are evaluated under three sub-headings as Functional-F- Ambulation-A- and Instrumental-E

    Change from Baseline Systolic Blood Pressure at 4 / 8 / 12 / 16 weeks

Study Arms (3)

T0-T1 period

NO INTERVENTION

It was a control period. Participants were asked to continue their routine activities for 4 weeks.

T1-T2 period (structured vestibular rehabilitation program)

EXPERIMENTAL

A structured vestibular rehabilitation program was applied in 50-minute sessions under the supervision of a physiotherapist once a week and as a home exercise program 3 days a week over 4 weeks.

Other: structured vestibular rehabilitation program

T2-T3 period

ACTIVE COMPARATOR

A structured vestibular rehabilitation program was applied in 50-minute sessions under the supervision of a physiotherapist once a week and as a home exercise program 3 days a week over 4 weeks. Afterwards, participants participated in the home program with telerehabilitation for 8 weeks.

Other: structured vestibular rehabilitation program

Interventions

The structured Vestibular rehabilitation protocol consisted of a structured vestibular rehabilitation program that included vestibular adaptation exercises, oculomotor exercises, static and dynamic balance exercises, and posture exercises.

T1-T2 period (structured vestibular rehabilitation program)T2-T3 period

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between 20-80 years old
  • Diagnosed with bilateral peripheral vestibular hypofunction by videonystagmography
  • Have symptoms for more than three months from onset of illness

You may not qualify if:

  • having no symptoms of bilateral peripheral vestibular hypofunction
  • having Meniere's disease, vestibular migraine and other undulating vestibular disorders, cognitive, visual, neurological or general motor impairment
  • having previously received vestibular rehabilitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, Beykoz, 34820, Turkey (Türkiye)

Location

MeSH Terms

Conditions

DizzinessKinesiophobiaSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPhobic DisordersAnxiety DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Asst Prof.

Study Record Dates

First Submitted

April 21, 2023

First Posted

May 10, 2023

Study Start

September 1, 2021

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

May 10, 2023

Record last verified: 2023-05

Locations